EA200600356A1 - Комбинированная терапия для гликемического контроля - Google Patents
Комбинированная терапия для гликемического контроляInfo
- Publication number
- EA200600356A1 EA200600356A1 EA200600356A EA200600356A EA200600356A1 EA 200600356 A1 EA200600356 A1 EA 200600356A1 EA 200600356 A EA200600356 A EA 200600356A EA 200600356 A EA200600356 A EA 200600356A EA 200600356 A1 EA200600356 A1 EA 200600356A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- glycemic control
- combined therapy
- diabetes mellitus
- diabetes
- niddm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49953503P | 2003-09-02 | 2003-09-02 | |
| PCT/IB2004/003082 WO2005020983A2 (en) | 2003-09-02 | 2004-09-02 | Combination therapy for glycaemic control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200600356A1 true EA200600356A1 (ru) | 2006-08-25 |
Family
ID=34272835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200600356A EA200600356A1 (ru) | 2003-09-02 | 2004-09-02 | Комбинированная терапия для гликемического контроля |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060287251A1 (enExample) |
| EP (1) | EP1663200A2 (enExample) |
| JP (1) | JP2007504213A (enExample) |
| KR (1) | KR20060119927A (enExample) |
| CN (1) | CN1845731A (enExample) |
| AU (1) | AU2004267955A1 (enExample) |
| BR (1) | BRPI0413204A (enExample) |
| CA (1) | CA2536432A1 (enExample) |
| EA (1) | EA200600356A1 (enExample) |
| IL (1) | IL173844A0 (enExample) |
| MX (1) | MXPA06002127A (enExample) |
| NO (1) | NO20061085L (enExample) |
| WO (1) | WO2005020983A2 (enExample) |
| ZA (1) | ZA200601770B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0526291D0 (en) * | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
| FR2896157B1 (fr) * | 2006-01-13 | 2008-09-12 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline. |
| GB0623892D0 (en) * | 2006-11-29 | 2007-01-10 | Medical Res Council Technology | Assay |
| CN102933598A (zh) * | 2010-03-26 | 2013-02-13 | 诺沃—诺迪斯克有限公司 | 新型胰高血糖素类似物 |
| CA2851690C (en) * | 2011-10-28 | 2022-07-26 | Sanofi-Aventis Deutschland Gmbh | Treatment protocol of diabetes type 2 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19823831A1 (de) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| DE29924609U1 (de) * | 1999-05-28 | 2004-04-22 | Probiodrug Ag | Neue Effektoren von Dipeptidylpeptidase IV |
| US20030139434A1 (en) * | 2000-01-21 | 2003-07-24 | Bork Balkan | Combinations comprising dipeptidylpeptidase-iv inhibitor |
| US6890905B2 (en) * | 2001-04-02 | 2005-05-10 | Prosidion Limited | Methods for improving islet signaling in diabetes mellitus and for its prevention |
| JP2005527504A (ja) * | 2002-02-28 | 2005-09-15 | プロシディオン・リミテッド | グルタミニルを基礎するｄｐｉｖ阻害剤 |
| EP1543023B1 (en) * | 2002-09-18 | 2010-03-17 | Prosidion Limited | Secondary binding site of dipeptidyl peptidase iv (dp iv) |
-
2004
- 2004-09-02 JP JP2006525215A patent/JP2007504213A/ja not_active Withdrawn
- 2004-09-02 WO PCT/IB2004/003082 patent/WO2005020983A2/en not_active Ceased
- 2004-09-02 BR BRPI0413204-1A patent/BRPI0413204A/pt not_active IP Right Cessation
- 2004-09-02 EP EP04769446A patent/EP1663200A2/en not_active Withdrawn
- 2004-09-02 AU AU2004267955A patent/AU2004267955A1/en not_active Abandoned
- 2004-09-02 US US10/570,113 patent/US20060287251A1/en not_active Abandoned
- 2004-09-02 EA EA200600356A patent/EA200600356A1/ru unknown
- 2004-09-02 MX MXPA06002127A patent/MXPA06002127A/es not_active Application Discontinuation
- 2004-09-02 KR KR1020067004354A patent/KR20060119927A/ko not_active Withdrawn
- 2004-09-02 CN CNA2004800251945A patent/CN1845731A/zh active Pending
- 2004-09-02 CA CA002536432A patent/CA2536432A1/en not_active Abandoned
-
2006
- 2006-02-21 IL IL173844A patent/IL173844A0/en unknown
- 2006-02-28 ZA ZA200601770A patent/ZA200601770B/en unknown
- 2006-03-06 NO NO20061085A patent/NO20061085L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL173844A0 (en) | 2006-07-05 |
| WO2005020983A3 (en) | 2005-07-28 |
| CN1845731A (zh) | 2006-10-11 |
| AU2004267955A1 (en) | 2005-03-10 |
| MXPA06002127A (es) | 2006-05-31 |
| ZA200601770B (en) | 2007-07-25 |
| EP1663200A2 (en) | 2006-06-07 |
| BRPI0413204A (pt) | 2006-10-03 |
| US20060287251A1 (en) | 2006-12-21 |
| NO20061085L (no) | 2006-05-31 |
| KR20060119927A (ko) | 2006-11-24 |
| JP2007504213A (ja) | 2007-03-01 |
| WO2005020983A2 (en) | 2005-03-10 |
| CA2536432A1 (en) | 2005-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200502385A (en) | Modulation of forkhead box o1a expression | |
| DE602004009295D1 (de) | 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie | |
| EA200600235A1 (ru) | Трёхзамещённые производные арилов и гетероарилов в качестве модуляторов метаболизма и профилактика и лечение связанных с ними нарушений | |
| DE602004022982D1 (de) | Verwendung von treprostinil zur verbesserung der nierenfunktion | |
| ATE462427T1 (de) | Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| NO20072136L (no) | Substans som fremmer GH-sekresjon og anvendelse derav | |
| WO2004058158A3 (en) | Treatment of metastatic cancer with the b-subunit of shiga toxin | |
| IL186356A0 (en) | Method of treating of preventing type-2 diabetes | |
| WO2005039626A3 (en) | Use of hydroxylated amino acids for treating diabetes | |
| EA200600778A1 (ru) | 1,3-диметилбутилкарбоксанилиды для борьбы с нежелательными микроорганизмами | |
| EA200600356A1 (ru) | Комбинированная терапия для гликемического контроля | |
| WO2003101284A3 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| WO2006017171A3 (en) | Methods of diagnosing & treating obesity, diabetes and insulin resistance | |
| DE602004018162D1 (de) | hERG1-KANAL-ÖFFNER ZUR BEHANDLUNG VON HERZARRYTHMIEN | |
| WO2003103606A3 (en) | Methods and compositions for treating and diagnosing diabetes | |
| WO2024229151A3 (en) | Multimeric coronavirus binding molecules and uses thereof | |
| EP2096120A3 (en) | Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome | |
| ATE354361T1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
| WO2003102161A3 (en) | Methods of diagnosing & treating diabetes and insulin resistance | |
| BRPI0506793A (pt) | métodos de tratamento de obesidade ou diabetes com o uso de nt-4/5 | |
| ATE328602T1 (de) | Kombinationspräparat zur behandlung des diabetes mellitus | |
| MXPA03006847A (es) | Compuestos quimicos. | |
| EP1465911A4 (en) | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DIABETES, INSULIN RESISTANCE AND DYSLIPIDEMIA |